Best Defensive Stocks To Buy For 2015: Palatin Technologies Inc. (PTN)
Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
Advisors' Opinion:- [By James E. Brumley]
For the third time in a little more than three months I find myself singing the praises of Palatin Technologies, Inc. (NYSEMKT:PTN), suggesting it is a "buy" ... at least to nimble and cautious speculators. It's a rarity, as I tend not to like beating a dead horse (personal preference). PTN, however, is one of those rare cases where the message deserves to be delivered again, as there's still a lot of opportunity left for newcomers to tap into.
source from Top Penny Stocks For 2015:http://www.topstocksforum.com/best-defensive-stocks-to-buy-for-2015.html
No comments:
Post a Comment